Nicholas Naclerio, Tom Willis, Mostofa Ronaghi, Kim Blickenstaff, Jacqueline Barton | GenomeWeb

Nicholas Naclerio has been appointed president of ParAllele BioScience, the company said last week. Naclerio comes to the South San Francisco genotyping company from a stint as an independent consultant for life sciences and venture capital companies. Before that, he was chief business officer of protein chip company Zyomyx between November 2001 and early 2002.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.